Dicerna Pharmaceuticals (DRNA) Announces First Quarter 2014 Financial And Operational Results
5/14/2014 7:03:27 AM
Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced operational and financial results for the quarter ending March 31, 2014.
“2014 thus far has been highlighted by a series of important events for Dicerna. We recently announced the achievement of a major milestone in our company’s history with the initiation of a Phase 1 clinical trial of DCR-MYC in solid tumors and hematological malignancies.
Help employers find you! Check out all the jobs and post your resume.
comments powered by